| Literature DB >> 8989166 |
Abstract
Lung transplantation is an option for appropriately selected patients with end-stage emphysema caused by alpha 1-antitrypsin deficiency. The functional results have been excellent after single or bilateral lung transplantation, and the medium-term survival results have been good. However, the role of alpha 1-antitrypsin replacement therapy after lung transplantation remains uncertain, and further investigation is needed.Entities:
Mesh:
Substances:
Year: 1996 PMID: 8989166 DOI: 10.1378/chest.110.6_supplement.284s
Source DB: PubMed Journal: Chest ISSN: 0012-3692 Impact factor: 9.410